Critical Contrast: Biolase (BIOL) & ArthroCare (ARTC)

Biolase (NASDAQ: BIOL) and ArthroCare (NASDAQ:ARTC) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Valuation and Earnings

This table compares Biolase and ArthroCare’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Biolase $51.81 million 0.66 -$15.37 million ($0.31) -1.45
ArthroCare N/A N/A N/A $0.40 N/A

ArthroCare has lower revenue, but higher earnings than Biolase. Biolase is trading at a lower price-to-earnings ratio than ArthroCare, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

38.8% of Biolase shares are owned by institutional investors. 7.1% of Biolase shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current recommendations for Biolase and ArthroCare, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biolase 0 0 1 0 3.00
ArthroCare 0 0 0 0 N/A

Biolase currently has a consensus target price of $2.50, suggesting a potential upside of 455.56%.


This table compares Biolase and ArthroCare’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Biolase -36.28% -74.51% -40.81%
ArthroCare N/A N/A N/A

Biolase Company Profile

BIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers. It offers two categories of laser system products: WaterLase (all-tissue) systems and Diode (soft tissue) systems. Its brand, WaterLase, uses a combination of water and laser energy to perform procedures performed using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. It also offers its Diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its Waterlase and Diode systems use disposable laser tips of differing sizes and shapes depending on the procedures being performed.

ArthroCare Company Profile

ArthroCare Corporation (ArthroCare) is a medical device company. ArthroCare develops and manufactures surgical devices, instruments, and implants. Its devices enable surgical procedures and enable new minimally invasive procedures. Many of ArthroCare’s devices use its Coblation technology. This technology dissolves target tissue and limits damage to surrounding healthy tissue. ArthroCare also develops surgical devices utilizing other patented technology, including its OPUS line of fixation products, as well as re-usable surgical instruments. ArthroCare’s two core product consists of sports medicine and ear, nose, and throat (ENT), as well as other areas, such as spine, wound care, urology and gynecology. It’s Sports Medicine, ENT and other products are marketed and sold through two principal geographic distribution channels: Americas (North and South America) and International (all other geographies). In May 2014, Smith & Nephew PLC acquired the Company.

Receive News & Ratings for Biolase Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biolase and related companies with's FREE daily email newsletter.

Leave a Reply